The regulatory and legal status of BPC-157 is that of an unapproved research compound in the United States and in most global jurisdictions, with no marketing authorization from any major regulatory agency for human therapeutic use
An unusual feature reported in the literature is timing: in some studies, DSIP given during the day was associated with improved sleep that night , rather than acting as an immediate, bedtime sedative
Investigating the effects of Argireline in a skin serum containing hyaluronic acids on skin surface wrinkles using the Visia Complexion Analysis camera system for objective skin analysis
Over time, environmental damage, pollution, sun exposure, and stress can deplete glutathione levelsleading to dullness, hyperpigmentation, and premature aging
Tumor-associated macrophages remodel the suppressive tumor immune microenvironment and targeted therapy for immunotherapy